{"id":"solaraze-3-topical-gel","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"burning sensation"},{"rate":"10-20%","effect":"redness"},{"rate":"5-10%","effect":"itching"}]},"_chembl":{"chemblId":"CHEMBL2108694","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Tazarotene works by binding to retinoic acid receptors, which are transcription factors that regulate the expression of genes involved in cell growth and differentiation. This leads to an inhibition of cell proliferation and an induction of cell differentiation, resulting in a reduction in the severity of psoriasis symptoms.","oneSentence":"Solaraze 3% Topical Gel is a topical gel formulation of tazarotene, a retinoid that modulates the expression of genes involved in cell proliferation and differentiation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:14.958Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe plaque psoriasis"}]},"trialDetails":[{"nctId":"NCT07475663","phase":"PHASE3","title":"Counterpain PXM Versus Diclofenac Versus Piroxicam","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Indonesia","startDate":"2025-11-04","conditions":"Ankle Sprain, Back Pain, Osteoarthritis (OA) of the Knee","enrollment":180},{"nctId":"NCT07212647","phase":"NA","title":"Home-Based Strategies for Knee Osteoarthritis","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2025-10-09","conditions":"Knee Osteoarthritis, Knee Osteoarthritis (Knee OA)","enrollment":83},{"nctId":"NCT07079969","phase":"PHASE2","title":"Effects of Photobiomodulation and Topical Diclofenac on Inflammation and Pain in Knee Osteoarthritis (EPIC-KO)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04","conditions":"Knee Pain Chronic","enrollment":32},{"nctId":"NCT07060976","phase":"NA","title":"To Check Dermatological Safety of Test Products by 24 Hours Patch Testing","status":"COMPLETED","sponsor":"Novamed Laboratories Pvt. Ltd.","startDate":"2025-07-21","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT05877027","phase":"NA","title":"Exercise vs. Topical Diclofenac vs. PRP","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2024-03-20","conditions":"Gonarthrosis","enrollment":82},{"nctId":"NCT07145645","phase":"PHASE3","title":"Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-09-02","conditions":"Musculoskeletal Injury, Pediatrics, Sprain and Strain of Ankle","enrollment":60},{"nctId":"NCT07106333","phase":"NA","title":"Assessment of Ozone Therapy for Management of Post-Extraction Localized Alveolar Osteitis","status":"NOT_YET_RECRUITING","sponsor":"Menoufia University","startDate":"2025-08-01","conditions":"Alveolar Osteitis","enrollment":40},{"nctId":"NCT06905561","phase":"NA","title":"Topical Diclofenac for Prevention of Radiation-induced Dermatitis","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Hainan Medical University","startDate":"2025-02-13","conditions":"Head and Neck Tumor, Breast Cancer","enrollment":156},{"nctId":"NCT05882812","phase":"PHASE2","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-03","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":200},{"nctId":"NCT05050448","phase":"PHASE1, PHASE2","title":"Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2021-08-01","conditions":"Knee Osteoarthritis","enrollment":60},{"nctId":"NCT05968482","phase":"PHASE1","title":"Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants","status":"COMPLETED","sponsor":"Amzell","startDate":"2023-07-11","conditions":"Healthy","enrollment":74},{"nctId":"NCT06510062","phase":"PHASE1","title":"Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation","status":"COMPLETED","sponsor":"ZetrOZ, Inc.","startDate":"2024-07-22","conditions":"Measurement of Circulation on Anatomical Locations of the Body","enrollment":67},{"nctId":"NCT06257537","phase":"PHASE2","title":"Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2024-10-01","conditions":"Osteo Arthritis Knee, Arthritis","enrollment":300},{"nctId":"NCT05883241","phase":"PHASE1","title":"Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2023-06-01","conditions":"Bone Fracture, Fresh Fracture","enrollment":90},{"nctId":"NCT05254574","phase":"PHASE1","title":"Sustained Acoustic Medicine for Osteoarthritis Pain","status":"RECRUITING","sponsor":"ZetrOZ, Inc.","startDate":"2022-02-14","conditions":"Osteoarthritis","enrollment":200},{"nctId":"NCT05026320","phase":"PHASE2","title":"A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-08-08","conditions":"Soft Tissue Injury","enrollment":76},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT03172780","phase":"PHASE3","title":"A Bioequivalence Study Using Clinical Endpoint for Diclofenac Sodium Gel 1% in Osteoarthritis Knee\"","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Private Limited","startDate":"2017-05-24","conditions":"Osteoarthritis, Knee","enrollment":1220},{"nctId":"NCT02913521","phase":"PHASE3","title":"Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%","status":"COMPLETED","sponsor":"Akorn, Inc.","startDate":"2015-06","conditions":"Osteoarthritis, Knee","enrollment":934},{"nctId":"NCT02666846","phase":"PHASE1","title":"Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model","status":"COMPLETED","sponsor":"Futura Medical Developments Ltd.","startDate":"2015-03","conditions":"Pain","enrollment":60},{"nctId":"NCT04402047","phase":"NA","title":"Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2020-09-01","conditions":"Hand Osteoarthritis","enrollment":108},{"nctId":"NCT04511195","phase":"PHASE2","title":"Effectiveness and Safety of Sphaeralcea Angustifolia Standardized Extract as a Topical Treatment of Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2020-07-10","conditions":"Knee Osteoarthritis","enrollment":100},{"nctId":"NCT01962987","phase":"PHASE3","title":"A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2013-03","conditions":"Actinic Keratosis","enrollment":476},{"nctId":"NCT04341402","phase":"PHASE2","title":"Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study","status":"UNKNOWN","sponsor":"William N Handelman","startDate":"2020-05-01","conditions":"Tinea Unguium, Onychomycosis","enrollment":30},{"nctId":"NCT04270968","phase":"NA","title":"Shock Wave Therapy On Cervical Pain Following Neck Dissection Surgery","status":"COMPLETED","sponsor":"Qassim University","startDate":"2018-11-03","conditions":"Pain, Cervical Pain","enrollment":46},{"nctId":"NCT02952898","phase":"PHASE3","title":"Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses","status":"COMPLETED","sponsor":"Balmoral Medical company","startDate":"2016-10-27","conditions":"Actinic Keratosis","enrollment":665},{"nctId":"NCT03074162","phase":"PHASE1","title":"Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2017-04-20","conditions":"Healthy","enrollment":48},{"nctId":"NCT03020368","phase":"NA","title":"Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2017-01","conditions":"Rhizarthrosis","enrollment":52},{"nctId":"NCT03826550","phase":"PHASE3","title":"Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Encube Ethicals Pvt. Ltd.","startDate":"2018-01-12","conditions":"Actinic Keratoses","enrollment":655},{"nctId":"NCT02100670","phase":"PHASE3","title":"A Multicenter Efficacy Study of a Diclofenac+Menthol Gel in Subjects With Ankle Sprain","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-11-01","conditions":"Pain","enrollment":385},{"nctId":"NCT02400320","phase":"PHASE4","title":"Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and Menthol","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2016-03-01","conditions":"Skin Irritation","enrollment":""},{"nctId":"NCT02201238","phase":"PHASE1","title":"Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-10-01","conditions":"Pain","enrollment":18},{"nctId":"NCT02961855","phase":"PHASE4","title":"Efficacy and Safety of CLIFE1 Gel in Benign Anorectal Surgery","status":"COMPLETED","sponsor":"Hospital de Viladecans","startDate":"2011-01","conditions":"Fissure;Anal, Fistula;Rectal, Hemorrhoids","enrollment":120},{"nctId":"NCT01935531","phase":"PHASE4","title":"Effects of Topical Diclofenac on Tumor Metabolism","status":"COMPLETED","sponsor":"University Hospital Regensburg","startDate":"2013-06","conditions":"Actinic Keratoses","enrollment":38},{"nctId":"NCT01202799","phase":"PHASE1","title":"Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2010-09","conditions":"Pain","enrollment":30},{"nctId":"NCT02068859","phase":"PHASE3","title":"Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1%","status":"UNKNOWN","sponsor":"FPR Specialty Pharmacy","startDate":"2014-01","conditions":"Knee Pain Chronic, Knee Injuries","enrollment":106},{"nctId":"NCT01742663","phase":"PHASE1","title":"A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-10","conditions":"Actinic Keratosis","enrollment":435},{"nctId":"NCT01066520","phase":"PHASE3","title":"TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain","status":"COMPLETED","sponsor":"Biologische Heilmittel Heel GmbH","startDate":"2009-08","conditions":"Sprain of Ankle","enrollment":449}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Solaraze 3% Topical Gel","genericName":"Solaraze 3% Topical Gel","companyName":"Encube Ethicals Pvt. Ltd.","companyId":"encube-ethicals-pvt-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Solaraze 3% Topical Gel is a topical gel formulation of tazarotene, a retinoid that modulates the expression of genes involved in cell proliferation and differentiation. Used for Moderate to severe plaque psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}